Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
about
Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlookImproving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationMonitoring of the Immune Dysfunction in Cancer PatientsThe simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools.IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanomaTrial Watch: Adoptive cell transfer immunotherapy.Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapyAdoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients.Immunotherapy of human papilloma virus induced diseasePotential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.Identification and manipulation of tumor associated macrophages in human cancers.Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions.Immunotherapy in Melanoma: Recent Advances and Promising New Therapies.Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?Adoptive T-cell therapy: a need for standard immune monitoring.Vaccines for established cancer: overcoming the challenges posed by immune evasion.Adoptive Cellular Therapy (ACT) for Cancer Treatment.Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.Adoptive T cell therapy: An overview of obstacles and opportunities.The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy.Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma.A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer.IL-2 and Beyond in Cancer Immunotherapy.Therapeutic cancer vaccines.T cell receptor β-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma.
P2860
Q27004178-A2F8E5A3-7FA1-47D2-B222-F9EF592C2C0FQ28068378-E685E9BE-080C-48CC-9386-07312DCE80A0Q28072712-5D79E744-5A34-4239-A1BE-9A3A7069E058Q30528191-7C1D26A9-4F61-46D4-874D-51CC88CBBD24Q33849567-0B8E9B1B-CFD4-41B3-AFB9-270278F6BBB8Q36057432-B341468B-7A0F-45B7-BAF7-3ED576119388Q36107158-92BA97B2-4AA2-4C87-974D-CA075251933AQ36444798-DE4E1088-EBCC-4352-836A-2004F5AE3ADDQ36541008-999B5962-BD54-4EFC-969F-F1194F99BE6EQ37399278-536B8167-804D-4010-9A13-5D308C3C6D8AQ37969227-02B131A6-7081-42D6-AE37-34F88D7D660EQ37986559-715D5AE2-BBC8-4AB2-8CFF-54A69AD80887Q38149916-D893AF94-B23A-4C7C-B12E-0DECF362F534Q38199873-5211052D-E07E-415F-AE96-DFE6A4085B01Q38237522-76BA24E7-9C6E-4C5D-9A23-5E0089AEA503Q38525029-BB09EA80-15C4-4A6C-B612-1C039D35A54BQ38769021-F92B9409-0E33-45D6-860C-ECE91FC05F71Q38848219-5FA17C45-A03D-47DC-A44C-5D5EE926B85CQ39104547-114D0193-8E1A-4872-B29D-028BB21471F3Q39329596-0B4E82A8-E49D-4FA7-B0F2-F1122E649FECQ41673084-CB131FB1-F2BB-447E-8443-7D7589BE2283Q42229717-9E1511BE-846E-4400-A707-34640BE80703Q47157821-7B1A1EA8-D967-49C8-943A-4C0164A41A05Q50004232-4D23EFA3-BCAA-4AD0-94F7-23F01F8E8DD5Q50988785-4AD72897-56EC-4286-B67A-91F978D7866AQ53102661-9247D5BD-F464-42FB-AAD5-D00FEB0A6D5E
P2860
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Successful treatment of metast ...... ith low-dose interferon-alpha.
@ast
Successful treatment of metast ...... ith low-dose interferon-alpha.
@en
type
label
Successful treatment of metast ...... ith low-dose interferon-alpha.
@ast
Successful treatment of metast ...... ith low-dose interferon-alpha.
@en
prefLabel
Successful treatment of metast ...... ith low-dose interferon-alpha.
@ast
Successful treatment of metast ...... ith low-dose interferon-alpha.
@en
P2093
P2860
P1476
Successful treatment of metast ...... ith low-dose interferon-alpha.
@en
P2093
Caroline E van der Minne
Ellen Kapiteijn
Els M E Verdegaal
Jeanne A Q M J van Steijn
Johan W R Nortier
John B A G Haanen
Marten Visser
Sjoerd H van der Burg
Susanne Osanto
Tamara H Ramwadhdoebé
P2860
P2888
P304
P356
10.1007/S00262-011-1004-8
P577
2011-03-24T00:00:00Z